BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14565859)

  • 1. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
    Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
    J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells.
    Connett JM; Hunt SR; Hickerson SM; Wu SJ; Doherty GM
    J Interferon Cytokine Res; 2003 Nov; 23(11):621-30. PubMed ID: 14651776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
    Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
    Jaruga B; Hong F; Kim WH; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA.
    Harroch S; Revel M; Chebath J
    EMBO J; 1994 Apr; 13(8):1942-9. PubMed ID: 8168491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
    Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
    Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages.
    Paludan SR; Ellermann-Eriksen S; Lovmand J; Mogensen SC
    Scand J Immunol; 1999 Feb; 49(2):169-76. PubMed ID: 10075021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1995 Nov; 86(9):3373-80. PubMed ID: 7579440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed induction of 2-5AS in cells with HTLV-I is not associated with the fluctuation of IFN-receptor, IFN-regulatory factors (IRF-1 and IRF-2) or STAT-1 alpha.
    Yokosawa N; Indoh T; Kubota T; Yashiki T; Fujii N
    Microbiol Immunol; 1997; 41(1):63-6. PubMed ID: 9087969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway.
    Percario ZA; Giandomenico V; Fiorucci G; Chiantore MV; Vannucchi S; Hiscott J; Affabris E; Romeo G
    Cell Growth Differ; 1999 Apr; 10(4):263-70. PubMed ID: 10319996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma.
    Yim JH; Wu SJ; Lowney JK; Vander Velde TL; Doherty GM
    J Interferon Cytokine Res; 1999 Jul; 19(7):723-9. PubMed ID: 10454342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
    Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
    Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
    Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
    Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
    Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
    J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.